Telecare motivational interviewing for diabetes patient education and support: a randomised controlled trial based in primary care comparing nurse and peer supporter delivery

ISRCTN ISRCTN63151946
DOI https://doi.org/10.1186/ISRCTN63151946
Secondary identifying numbers N/A
Submission date
31/07/2006
Registration date
05/10/2006
Last edited
17/08/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Jeremy Dale
Scientific

Warwick Medical School
Medical School Building
Gibbet Hill campus
University of Warwick
Coventry
CV4 7AL
United Kingdom

Phone +44 (0) 2476 522891
Email Jeremy.Dale@warwick.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeQuality of life
Scientific titleTelecare motivational interviewing for diabetes patient education and support: a randomised controlled trial based in primary care comparing nurse and peer supporter delivery
Study acronymTelecare
Study objectivesTo enhance the well-being of patients living with type 2 diabetes through the provision of expert telecare (nurse or peer consultation by phone) following treatment change.
Ethics approval(s)The study has been granted ethical approval by the Warwickshire LREC Committee on 15.03.04 (ref.no.610)
Health condition(s) or problem(s) studiedType 2 diabetes
InterventionParticipants are randomly assigned to one of the three arms of the trial:
1. Telephone support provided by a diabetes specialist nurse
2. Telephone support provided by a peer supporter (i.e. also living with diabetes)
3. Standard care
Intervention typeOther
Primary outcome measureSelf-efficacy scores
Secondary outcome measuresClinical outcomes (HbA1c, cholesterol level, blood pressure, Body Mass Index [BMI])
Overall study start date01/10/2004
Completion date01/11/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants300
Key inclusion criteriaAdult patients with type 2 diabetes, for whom the most recent HbA1c is greater than 7.4%
Key exclusion criteria1. Patients receiving insulin therapy
2. Patients lacking a telephone
3. Those with severe accompanying disorders or judged by General Practitioner as likely to interfere with outcome interpretation
Date of first enrolment01/10/2004
Date of final enrolment01/11/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Warwick Medical School
Coventry
CV4 7AL
United Kingdom

Sponsor information

The BUPA Foundation (UK)
Charity

BUPA House
15-19 Bloomsbury Way
London
WC1A 2BA
United Kingdom

Phone +44 (0) 20 76562591
Email saunderl@bupa.com
Website http://www.bupafoundation.com
ROR logo "ROR" https://ror.org/04fskt963

Funders

Funder type

Government

The BUPA Foundation (UK)

No information available

Department of Health Ad Hoc Funding (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 28/06/2007 Yes No
Results article results 01/04/2009 Yes No

Editorial Notes

17/08/2018: Publication reference added